Rare Disease Genetic Testing Market to Reach USD 3.79 Billion by 2032 | Growth is Driven by Rising Demand for Early Diagnostic Solutions Globally – SNS Insider [Yahoo! Finance]
Quest Diagnostics Incorporated (DGX)
Last quest diagnostics incorporated earnings: 4/22 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
ir.questdiagnostics.com
Company Research
Source: Yahoo! Finance
Austin, Texas, Dec. 11, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, The Rare Disease Genetic Testing Market was valued at USD 1.05 billion in 2023 and is expected to reach USD 3.79 billion by 2032, growing at a CAGR of 15.36% over the forecast period of 2024-2032. According to this report, there is a greater need for early and accurate diagnostic solutions due to the incidence and prevalence of rare diseases. Based on advancements in sequencing technologies and expanding newborn screening programs, the study examines regional patterns in the use of genetic testing. Get a Sample Report of Rare Disease Genetic Testing Market: https://www.snsinsider.com/sample-request/6397 The U.S. Rare Disease Genetic Testing Market was valued at USD 0.31 billion in 2023 and is expected to reach USD 1.18 billion by 2032, growing at a CAGR of 16.01% over 2024-2032. The market for rare disease genetic testing is expanding in the U.S. due to strong federal initiatives, rising investments in pre
Show less
Read more
Impact Snapshot
Event Time:
DGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DGX alerts
High impacting Quest Diagnostics Incorporated news events
Weekly update
A roundup of the hottest topics
DGX
News
- Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease [Yahoo! Finance]Yahoo! Finance
- Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual DiseasePR Newswire
- Quest Diagnostics (NYSE:DGX) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $210.00 price target on the stock.MarketBeat
- Quest Diagnostics (NYSE:DGX) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=DGX&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street ZeMarketBeat
- Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year [Yahoo! Finance]Yahoo! Finance
DGX
Earnings
- 10/21/25 - Beat
DGX
Sec Filings
- 1/12/26 - Form 8-K
- 11/28/25 - Form 4
- 11/28/25 - Form 4
- DGX's page on the SEC website